R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid

This compound is a synthetic small molecule with the IUPAC name (2R)-6-methoxy‑2-{[4'‑methoxy-(1,1'‑biphenyl)–⁠⁠⁠⁠⁠⁠⁃⁃⁃⁃⁃⁃‍‍‍‍‍‍‌‌‌‌‌‌‌‌‌‌‌‎‎‎‎‏‏‏‏‏‏‎‎‎‎ ‎ ‎ ‎ ⁠ ⁠ ⁠ ⁠ ⁠ sulfonamido}hex‐​‐​ynoic acid. It has a molecular formula of C20H21NO6S and a molecular weight of approximately 403.45 g/mol. The compound is classified as an experimental drug and is not approved for clinical use. Its precise mechanism of action and therapeutic indication are not described in public databases; it appears to be primarily used as a research tool or chemical probe in biochemical studies rather than as an active pharmaceutical ingredient in any marketed medication[1][6]. No information on its pharmacological activity or clinical development status is available.

Other names

(2R)-6-methoxy-2-[4-(4-methoxyphenyl)benzenesulfonamido]hex-4-ynoic acid(2R)-6-methoxy-2-{[(4′-methoxy-[1,1′‑biphenyl]-4‑sulfonyl]amino}-4‑hexynoic acid(2R)-6-methoxy‑2‑{[4′‑methoxy–(1,1′–biphenyl)– ̶ ̶ ̶ –sulfonamido}hex– ̶ –ynoic acid